The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, H.
Right arrow Articles by Makino, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, H.
Right arrow Articles by Makino, I.

The Journal of Immunology, Vol 156, Issue 4 1601-1608, Copyright © 1996 by American Association of Immunologists


ARTICLES

Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway

H Tanaka, Y Makino, T Miura, F Hirano, K Okamoto, K Komura, Y Sato and I Makino
Second Department of Internal Medicine, Asahikawa Medical College, Japan.

The therapeutic effectiveness of ursodeoxycholic acid (UDCA) for various autoimmune liver diseases strongly indicates that UDCA possesses immunomodulatory activities. Experimental evidence also supports this notion, since, for example, UDCA has been shown to suppress secretion of IL-2, IL-4, and IFN-gamma from activated T lymphocytes, and Ig production from B lymphocytes. To investigate the mechanical background of UDCA-mediated immunomodulation, we asked whether UDCA interacts with the intracellular signal transduction pathway, especially whether it is involved in immunosuppressive glucocorticoid hormone action. For this purpose, we used a cloned Chinese hamster ovary cell line, CHOpMTGR, in which glucocorticoid receptor cDNA was stably integrated. In immunocytochemical analysis, we found that treatment with UDCA promoted the nuclear translocation of the glucocorticoid receptor in a ligand-independent fashion, which was further confirmed by immunoprecipitation assays. Moreover, the translocated glucocorticoid receptor demonstrated sequence-specific DNA binding activity. Transient transfection experiments revealed that treatment of the cells with UDCA marginally enhanced glucocorticoid- responsive gene expression. We also showed that UDCA suppressed IFN- gamma-mediated induction of MHC class II gene expression via the glucocorticoid receptor-mediated pathway. Together, UDCA-dependent promotion of translocation of the glucocorticoid receptor may be associated with, at least in part, its immunomodulatory action through glucocorticoid receptor-mediated gene regulation.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
S. Sola, J. D. Amaral, P. M. Borralho, R. M. Ramalho, R. E. Castro, M. M. Aranha, C. J. Steer, and C. M. P. Rodrigues
Functional Modulation of Nuclear Steroid Receptors by Tauroursodeoxycholic Acid Reduces Amyloid {beta}-Peptide-Induced Apoptosis
Mol. Endocrinol., October 1, 2006; 20(10): 2292 - 2303.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Miura, R. Ouchida, N. Yoshikawa, K. Okamoto, Y. Makino, T. Nakamura, C. Morimoto, I. Makino, and H. Tanaka
Functional Modulation of the Glucocorticoid Receptor and Suppression of NF-kappa B-dependent Transcription by Ursodeoxycholic Acid
J. Biol. Chem., December 7, 2001; 276(50): 47371 - 47378.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Okamoto, H. Tanaka, H. Ogawa, Y. Makino, H. Eguchi, S.-i. Hayashi, N. Yoshikawa, L. Poellinger, K. Umesono, and I. Makino
Redox-dependent Regulation of Nuclear Import of the Glucocorticoid Receptor
J. Biol. Chem., April 9, 1999; 274(15): 10363 - 10371.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Makino, N. Yoshikawa, K. Okamoto, K. Hirota, J. Yodoi, I. Makino, and H. Tanaka
Direct Association with Thioredoxin Allows Redox Regulation of Glucocorticoid Receptor Function
J. Biol. Chem., January 29, 1999; 274(5): 3182 - 3188.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Eickelberg, M. Roth, R. Lorx, V. Bruce, J. Rudiger, M. Johnson, and L.-H. Block
Ligand-independent Activation of the Glucocorticoid Receptor by beta 2-Adrenergic Receptor Agonists in Primary Human Lung Fibroblasts and Vascular Smooth Muscle Cells
J. Biol. Chem., January 8, 1999; 274(2): 1005 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. D. Fontes, S. Kanazawa, D. Jean, and B. M. Peterlin
Interactions between the Class II Transactivator and CREB Binding Protein Increase Transcription of Major Histocompatibility Complex Class II Genes
Mol. Cell. Biol., January 1, 1999; 19(1): 941 - 947.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. L. Crossin, M.-H. Tai, L. A. Krushel, V. P. Mauro, and G. M. Edelman
Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation
PNAS, March 18, 1997; 94(6): 2687 - 2692.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.